Nicorandil Improves postischemic Contractile function Independently of Direct Mycardial.Effects
- 1 May 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 15 (5) , 698-705
- https://doi.org/10.1097/00005344-199005000-00003
Abstract
We determined whether any of the antiischemic effects of nicorandil were due to direct cardioprotective effects such as potassium channel activation or to its peripheral hemodynamic effects. Nicorandil was administered either intravenously (i.v.) or directly into the ischemic coronary artery (i.c.) and compared with i.c. cromakalim (a potassium channel activator previously shown to improve reperfusion function directly in rat hearts) or vehicle for their ability to improve postischemic contractile function as measured by ultrasonic crystals in anesthetized dogs or in isolated perfused rat hearts. In a model of 25-min global ischemia and reperfusion in isolated perfused rat hearts, nicorandil (10–100 μM) did not improve reperfusion function or decrease LDH re-lease, although 300 μM nicorandil did protect the hearts. Cromakalim (7 μM)significantly improved reperfusion function and reduced lactate dehydrogenase (LDH) re-lease. In the dog studies, the left anterior descending coronary artery (LAD) was occluded for 15 min and was reperfused for 3 h. Nicorandil improved reperfusion function only when administered i.v., although i.c. cromakalim was efficacious in improving function. Neither nicorandil nor cromakalim improved collateral flow, although cromakalim significantly improved preischemic and reperfusion blood flows, particularly in the subepicardial region. Although i.c. treatment with cromakalim and nicorandil did not result in significant changes in peripheral hemodynamic status, i.v. nicorandil reduced both preload and afterload. Thus, at the dose used, nicorandil does not appear to have direct myocardial protective effects and the beneficial effects of nicorandil do not appear to be related to potassium channel activation in the myocardium. Potassium channel activation by cromakalim does result in direct cardioprotective effects whereas nicorandil appears to be dependent on peripheral actions for its efficacy.This publication has 12 references indexed in Scilit:
- The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytesBiochemical and Biophysical Research Communications, 1988
- Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels.Journal of Biological Chemistry, 1988
- Effect of Intracoronary Diltiazem on ST-Segment Elevation and Myocardial Blood Flow During Pacing-Induced IschemiaJournal of Cardiovascular Pharmacology, 1987
- Comparative Effects of Nicorandil, a Nicotinamide Nitrate Derivative, and Nifedipine on Myocardial Reperfusion Injury in DogsJournal of Cardiovascular Pharmacology, 1987
- Salutary action of nicorandil, a new antianginal drug, on myocardial metabolism during ischemia and on postischemic function in a canine preparation of brief, repetitive coronary artery occlusions: comparison with isosorbide dinitrate.Circulation, 1987
- Recovery of contractile function in post-ischaemic reperfused myocardium of conscious dogs: influence of nicorandil, a new antianginal agentCardiovascular Research, 1986
- Improved Recovery of Myocardial Segment Function Following a Short Coronary Occlusion in Dogs by Nicorandil, a Potential New Antianginal Agent, and NifedipineJournal of Cardiovascular Pharmacology, 1985
- EFFECTS OF SG-75 (NICORANDIL) ON ELECTRICAL-ACTIVITY OF CANINE CARDIAC PURKINJE-FIBERS - POSSIBLE INCREASE IN POTASSIUM CONDUCTANCE1983
- Relative error and variability in blood flow measurements with radiolabeled microspheresAmerican Journal of Physiology-Heart and Circulatory Physiology, 1982
- EFFECT OF NITROGLYCERIN ON PERIPHERAL-BLOOD FLOW DISTRIBUTION AND VENOUS RETURN1978